Janney Daniel

DirectorKrystal Biotech, Inc. (KRYS) · full profile →Form 4 · filed Feb 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$16.1M
Net Open-Market Flow
-$16.1M
Transactions
22
21 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 26, 2026Sell(S)3K$276.32$729K85K
Feb 26, 2026Sell(S)5K$275.28$1.4M88K
Feb 25, 2026Sell(S)700$275.00$193K93K
Feb 24, 2026Sell(S)2K$267.37$506K99K
Feb 24, 2026Sell(S)4K$266.62$1.2M100K
Feb 24, 2026Sell(S)2K$265.54$426K105K
Feb 24, 2026Sell(S)900$264.60$238K106K
Feb 24, 2026Sell(S)62$263.05$16K107K
Feb 24, 2026Sell(S)373$271.09$101K0
Feb 24, 2026Sell(S)370$269.83$100K373
Feb 24, 2026Option exercise(M)38K$2.46$93K38K
Feb 24, 2026Sell(S)569$262.91$150K37K
Feb 24, 2026Sell(S)2K$264.12$458K36K
Feb 24, 2026Sell(S)4K$265.08$943K32K
Feb 24, 2026Sell(S)9K$266.18$2.4M23K
Feb 24, 2026Sell(S)12K$266.97$3.1M11K
Feb 24, 2026Sell(S)7K$268.04$1.8M5K
Feb 24, 2026Sell(S)4K$268.97$1.1M743
Feb 24, 2026Sell(S)2K$274.90$667K94K
Feb 24, 2026Sell(S)2K$268.67$450K97K
Feb 24, 2026Sell(S)930$269.50$251K96K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2026Option exercise(M)38K$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001711279-26-000021) within minutes of acceptance. Every field above traces to the original document. Verify it directly: